London, United Kingdom

Jonathan C M Wan

This inventor holds 1 USPTO granted patent. Top assignee: Cancer Research Technology Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan C M Wan. Retrieved from https://idiyas.com/inventor/jonathan-c-m-wan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jonathan C. M. Wan and His Work in Cancer Detection.

Introduction

Jonathan C. M. Wan is an inventor associated with London, Great Britain, and Cancer Research Technology Limited. His patent work focuses on detecting cell-free DNA, including circulating tumour DNA, in samples obtained from patients.

Latest Patents

The supplied information identifies one patent associated with Wan: “Variant detection.” The invention describes a computer-implemented method for detecting target cell-free DNA by examining sequence reads across at least two mutation-containing loci associated with a patient’s tumour. The method can group reads into families, calculate mutant allele fractions across the selected loci, and use those fractions to classify whether the sample contains the target DNA. Related methods and systems are also described.

Career Highlights

Wan’s listed patent activity connects his work with cancer research and the development of methods for identifying tumour-related genetic material. The supplied data attributes 1 patent to him and names Cancer Research Technology Limited as his company.

Collaborations

The supplied information lists Eyal Fisher and Katrin Heider as Wan’s coworkers. Their inclusion indicates professional connections associated with his work, though no specific collaborative roles are provided.

Conclusion

Jonathan C. M. Wan’s identified invention applies genetic sequencing analysis to the detection of tumour-associated cell-free DNA, reflecting a patent contribution in cancer research technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…